PoliticalRepoPoliticalRepo

European Union · Question · QUESTION_WRITTEN

E-10-2025-004090

The risks to access and the cost of medicines as a result of the price war declared by US President Donald Trump

answeredEuropean Union· European Parliament· EN

Introduced

16 October 2025

Last action

Status

answered

Sponsors

Subjects

Discovery layer

Source updated

19 January 2026

Records

Official question E-10-2025-004090 from European Union at European Parliament. Dated 16 October 2025. Status: answered.

Timeline

No timeline events have been ingested for this record yet.

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

5 official files

The risks to access and the cost of medicines as a result of the price war declared by US President Donald Trump

View fileDownload file

  • The risks to access and the cost of medicines as a result of the price war declared by US President Donald Trump

    QUESTION_WRITTEN · EN · 5 November 2025

    ViewDownloadOpen at official source

  • The risks to access and the cost of medicines as a result of the price war declared by US President Donald Trump

    QUESTION_WRITTEN · EN · 5 November 2025

    DownloadOpen at official source

  • Answer

    QUESTION_WRITTEN_ANSWER · 19 January 2026

    ViewDownloadOpen at official source

  • Los riesgos para el acceso a los medicamentos y su coste como consecuencia de la guerra de precios declarada por el presidente de los Estados Unidos, Donald Trump

    QUESTION_WRITTEN · ES · 5 November 2025

    ViewDownloadOpen at official source

  • Los riesgos para el acceso a los medicamentos y su coste como consecuencia de la guerra de precios declarada por el presidente de los Estados Unidos, Donald Trump

    QUESTION_WRITTEN · ES · 5 November 2025

    DownloadOpen at official source

Sponsors

No sponsors or actors listed by the source.

Related records

No cross-record relationships stored yet.

Sources

PoliticalRepo is an index and interpretation layer, not the authoritative legal source.